"Depuis 1969, l’hôpital pneumologique et cardiovasculaire Louis Pradel concentre des expertises de pointe dans de nombreuses spécialités : cardiologie, chirurgie cardiovasculaire et thoracique, cardio-pédiatrie médico-chirurgicale, endocrinologie, pneumologie, anesthésie-réanimation et soins critiques."

During the past decade, Hôpital Louis Pradel conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 26 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 14 clinical trials were completed. i.e. 24.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Louis Pradel" #1 sponsor was "Hospices Civils de Lyon" with 46 trials, followed by "Boehringer Ingelheim" with 11 trials sponsored, "Actelion" with 9 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 8 trials sponsored and "Hoffmann-La Roche" with 8 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Louis Pradel" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "Hospices Civils de Lyon" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator and "Takeda Development Center Americas, Inc." with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Louis Pradel" are "Idiopathic Pulmonary Fibrosis" (12 trials), "Pulmonary Arterial Hypertension" (9 trials), "Hemophilia A" (6 trials), "Coronary Artery Disease" (5 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "Hôpital Louis Pradel" in a lesser frequency.

Most popular intervention types in "Hôpital Louis Pradel" are "Drug" (79 trials), "Device" (31 trials), "Other" (22 trials), "Procedure" (14 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Nintedanib" (6 trials), "Pemetrexed" (5 trials), "Emicizumab" (4 trials) and "MRI" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Louis Pradel" are 159 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 48 active trials in "Hôpital Louis Pradel". 5 are not yet recruiting, 33 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 83 completed trials in Hôpital Louis Pradel, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Louis Pradel, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 40 trials that are defined as “Not Applicable".